BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion.
Experimental bone marrow transplantation (BMT) in mice is commonly used to assess the role of immune cell-specific genes in various pathophysiological settings. The application of BMT in obesity research is hampered by the significant reduction in high-fat diet (HFD)-induced obesity. We set out to c...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5406023?pdf=render |
id |
doaj-adc73015398d4b86af1b275949ba731c |
---|---|
record_format |
Article |
spelling |
doaj-adc73015398d4b86af1b275949ba731c2020-11-25T01:35:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01124e017552410.1371/journal.pone.0175524BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion.Saeed KatiraeiLisa R HovingLianne van BeekSharida MohamedhoeseinFrançoise CarlottiJanna A van DiepenPatrick C N RensenMihai G NeteaKo Willems van DijkJimmy F P BerbéeVanessa van HarmelenExperimental bone marrow transplantation (BMT) in mice is commonly used to assess the role of immune cell-specific genes in various pathophysiological settings. The application of BMT in obesity research is hampered by the significant reduction in high-fat diet (HFD)-induced obesity. We set out to characterize metabolic tissues that may be affected by the BMT procedure and impair the HFD-induced response. Male C57BL/6 mice underwent syngeneic BMT using lethal irradiation. After a recovery period of 8 weeks they were fed a low-fat diet (LFD) or HFD for 16 weeks. HFD-induced obesity was reduced in mice after BMT as compared to HFD-fed control mice, characterized by both a reduced fat (-33%; p<0.01) and lean (-11%; p<0.01) mass, while food intake and energy expenditure were unaffected. As compared to control mice, BMT-treated mice had a reduced mature adipocyte volume (approx. -45%; p<0.05) and reduced numbers of preadipocytes (-38%; p<0.05) and macrophages (-62%; p<0.05) in subcutaneous, gonadal and visceral white adipose tissue. In BMT-treated mice, pancreas weight (-46%; p<0.01) was disproportionally decreased. This was associated with reduced plasma insulin (-68%; p<0.05) and C-peptide (-37%; p<0.01) levels and a delayed glucose clearance in BMT-treated mice on HFD as compared to control mice. In conclusion, the reduction in HFD-induced obesity after BMT in mice is at least partly due to alterations in the adipose tissue cell pool composition as well as to a decreased pancreatic secretion of the anabolic hormone insulin. These effects should be considered when interpreting results of experimental BMT in metabolic studies.http://europepmc.org/articles/PMC5406023?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Saeed Katiraei Lisa R Hoving Lianne van Beek Sharida Mohamedhoesein Françoise Carlotti Janna A van Diepen Patrick C N Rensen Mihai G Netea Ko Willems van Dijk Jimmy F P Berbée Vanessa van Harmelen |
spellingShingle |
Saeed Katiraei Lisa R Hoving Lianne van Beek Sharida Mohamedhoesein Françoise Carlotti Janna A van Diepen Patrick C N Rensen Mihai G Netea Ko Willems van Dijk Jimmy F P Berbée Vanessa van Harmelen BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion. PLoS ONE |
author_facet |
Saeed Katiraei Lisa R Hoving Lianne van Beek Sharida Mohamedhoesein Françoise Carlotti Janna A van Diepen Patrick C N Rensen Mihai G Netea Ko Willems van Dijk Jimmy F P Berbée Vanessa van Harmelen |
author_sort |
Saeed Katiraei |
title |
BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion. |
title_short |
BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion. |
title_full |
BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion. |
title_fullStr |
BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion. |
title_full_unstemmed |
BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion. |
title_sort |
bmt decreases hfd-induced weight gain associated with decreased preadipocyte number and insulin secretion. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Experimental bone marrow transplantation (BMT) in mice is commonly used to assess the role of immune cell-specific genes in various pathophysiological settings. The application of BMT in obesity research is hampered by the significant reduction in high-fat diet (HFD)-induced obesity. We set out to characterize metabolic tissues that may be affected by the BMT procedure and impair the HFD-induced response. Male C57BL/6 mice underwent syngeneic BMT using lethal irradiation. After a recovery period of 8 weeks they were fed a low-fat diet (LFD) or HFD for 16 weeks. HFD-induced obesity was reduced in mice after BMT as compared to HFD-fed control mice, characterized by both a reduced fat (-33%; p<0.01) and lean (-11%; p<0.01) mass, while food intake and energy expenditure were unaffected. As compared to control mice, BMT-treated mice had a reduced mature adipocyte volume (approx. -45%; p<0.05) and reduced numbers of preadipocytes (-38%; p<0.05) and macrophages (-62%; p<0.05) in subcutaneous, gonadal and visceral white adipose tissue. In BMT-treated mice, pancreas weight (-46%; p<0.01) was disproportionally decreased. This was associated with reduced plasma insulin (-68%; p<0.05) and C-peptide (-37%; p<0.01) levels and a delayed glucose clearance in BMT-treated mice on HFD as compared to control mice. In conclusion, the reduction in HFD-induced obesity after BMT in mice is at least partly due to alterations in the adipose tissue cell pool composition as well as to a decreased pancreatic secretion of the anabolic hormone insulin. These effects should be considered when interpreting results of experimental BMT in metabolic studies. |
url |
http://europepmc.org/articles/PMC5406023?pdf=render |
work_keys_str_mv |
AT saeedkatiraei bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT lisarhoving bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT liannevanbeek bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT sharidamohamedhoesein bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT francoisecarlotti bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT jannaavandiepen bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT patrickcnrensen bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT mihaignetea bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT kowillemsvandijk bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT jimmyfpberbee bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion AT vanessavanharmelen bmtdecreaseshfdinducedweightgainassociatedwithdecreasedpreadipocytenumberandinsulinsecretion |
_version_ |
1725066288893526016 |